RenBio, Inc

New York, New York, United States
Purpose
to evaluate a DNA/EP-based platform technology for the delivery of IgA antibodies which has the potential to provide affordable, widespread protection from many infectious diseases
Grantee
Division
Global Health
Date
MARCH 2018
Region served
GLOBAL
Committed amount
$751,751
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
19
Grantee location
New York, New York, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.